This study tested a new vaccine called IVX-A12 that targets two respiratory viruses: RSV and hMPV. It involved 264 healthy adults aged 60 to 85. The goal was to see if the vaccine is safe and boosts the immune system to fight these viruses.
Phase: PHASE2 • Sponsor: Icosavax, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:02 UTC